tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Ascletis Pharma Begins U.S. Phase I Trial for Psoriasis Drug ASC50
Company AnnouncementsAscletis Pharma Begins U.S. Phase I Trial for Psoriasis Drug ASC50
5d ago
1672
Ascletis Pharma to Present Promising Obesity Treatments at ADA Scientific Sessions
PremiumCompany Announcements
Ascletis Pharma to Present Promising Obesity Treatments at ADA Scientific Sessions
14d ago
1672
Ascletis Pharma’s Denifanstat Achieves Breakthrough in Acne Treatment
PremiumCompany Announcements
Ascletis Pharma’s Denifanstat Achieves Breakthrough in Acne Treatment
19d ago
1672
Ascletis Faces Import Ban and Sanction in ITC Ruling
PremiumCompany Announcements
Ascletis Faces Import Ban and Sanction in ITC Ruling
24d ago
1672
Ascletis Pharma Secures FDA Clearance for Psoriasis Drug Trial
PremiumCompany Announcements
Ascletis Pharma Secures FDA Clearance for Psoriasis Drug Trial
1M ago
1672
Ascletis Pharma Inc. Announces Successful AGM with Key Resolutions Passed
PremiumCompany AnnouncementsAscletis Pharma Inc. Announces Successful AGM with Key Resolutions Passed
1M ago
1672
Ascletis Pharma Initiates U.S. Clinical Study on Obesity Treatment
Premium
Company Announcements
Ascletis Pharma Initiates U.S. Clinical Study on Obesity Treatment
1M ago
1672
Ascletis to Present ASC47 Weight Loss Drug at European Congress
Premium
Company Announcements
Ascletis to Present ASC47 Weight Loss Drug at European Congress
2M ago
1672
Ascletis Pharma Announces 2025 Annual General Meeting Agenda
PremiumCompany Announcements
Ascletis Pharma Announces 2025 Annual General Meeting Agenda
2M ago
1672
Ascletis Pharma Reports Positive Phase Ib Results for ASC30 in Obesity Treatment
PremiumCompany Announcements
Ascletis Pharma Reports Positive Phase Ib Results for ASC30 in Obesity Treatment
2M ago
1672
Ascletis Pharma Reports Promising Phase Ib Results for ASC30 in Obesity Treatment
PremiumCompany Announcements
Ascletis Pharma Reports Promising Phase Ib Results for ASC30 in Obesity Treatment
3M ago
1672
Ascletis Pharma Reports Increased R&D Investment Amid 2024 Financial Results
PremiumCompany Announcements
Ascletis Pharma Reports Increased R&D Investment Amid 2024 Financial Results
3M ago
1672
Ascletis Pharma Reports Positive Phase Ib Results for ASC47 and FDA Clearance for Combination Study
PremiumCompany AnnouncementsAscletis Pharma Reports Positive Phase Ib Results for ASC47 and FDA Clearance for Combination Study
3M ago
1672
Ascletis Pharma Reports Positive Interim Results for ASC30 Obesity Treatment
Premium
Company Announcements
Ascletis Pharma Reports Positive Interim Results for ASC30 Obesity Treatment
4M ago
1672
Ascletis Pharma’s EGM Approves Key Share Schemes
Premium
Company Announcements
Ascletis Pharma’s EGM Approves Key Share Schemes
5M ago
1672
Ascletis Announces Positive Phase Ia Results for ASC30 in Obesity Treatment
PremiumCompany Announcements
Ascletis Announces Positive Phase Ia Results for ASC30 in Obesity Treatment
5M ago
1672
Ascletis Pharma to Discuss New Share Incentive Schemes at Upcoming EGM
PremiumCompany Announcements
Ascletis Pharma to Discuss New Share Incentive Schemes at Upcoming EGM
5M ago
1672
Ascletis Pharma Proposes New Incentive Schemes to Attract Talent
PremiumCompany Announcements
Ascletis Pharma Proposes New Incentive Schemes to Attract Talent
5M ago
1672
Ascletis Pharma Announces EGM Book Closure Period
PremiumCompany Announcements
Ascletis Pharma Announces EGM Book Closure Period
5M ago
1672
Ascletis Pharma’s ASC47 Shows Promising Weight Loss Results
PremiumCompany AnnouncementsAscletis Pharma’s ASC47 Shows Promising Weight Loss Results
6M ago
1672
Ascletis Pharma Advances in Phase III Acne Treatment Trial
Premium
Company Announcements
Ascletis Pharma Advances in Phase III Acne Treatment Trial
7M ago
1672
Ascletis Pharma Unveils Promising ASC47 Weight Loss Results
Premium
Company Announcements
Ascletis Pharma Unveils Promising ASC47 Weight Loss Results
8M ago
1672

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >